Presented for research literature review only Tian J et al
Research suggests a slow build across the activation and consolidation phases rather than an overnight effect

According to Yucca Health's safety information pages, GLP-1 medications like semaglutide and tirzepatide have important contraindications: Do not use if: You or a family member has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) You have had a severe allergic reaction to semaglutide, tirzepatide, or any ingredients in the formulation You are pregnant, planning to become pregnant, or breastfeeding (GLP-1 medications are not recommended during pregnancy or breastfeeding) Use with caution and close medical supervision if you have: History of pancreatitis or pancreas problems Kidney problems or history of kidney disease Severe gastrointestinal issues such as gastroparesis Type 2 diabetes with history of diabetic retinopathy (semaglutide specifically) Are taking other medications including insulin or sulfonylureas (increased risk of hypoglycemia) The provider reviewing your intake will screen for these factors and may decline to prescribe if contraindications are present or request additional information before making a determination

A dermatologist or physician typically evaluates each patients suitability before starting GHK-Cu
Every other day (EOD) is a common middle ground
The Series CC dividend is payable on June 15, 2026, to holders of record as of the close of business on May 29, 2026